Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88074194 | FILING DATE | 08/10/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | INGOLD, GERALDINE F |
L.O. ASSIGNED | N30-NOT FOUND |
PUB INFORMATION |
|||
RUN DATE | 06/13/2019 | ||
PUB DATE | N/A | ||
STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
STATUS DATE | 06/13/2019 | ||
LITERAL MARK ELEMENT | MONJUVI | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
44D | YES | 44D | NO | 44D | NO |
44E | NO | 44E | YES | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | MONJUVI |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | MorphoSys AG |
ADDRESS | Semmelweisstrasse 7 Planegg, D-82152 |
ENTITY | 25 |
CITIZENSHIP | Germany |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON European Union |
APPLICATION NO. | 17893288 |
APPLICATION FILING DATE | 04/27/2018 |
FOREIGN REG NO. | 017893288 |
FOREIGN REG DATE | 10/26/2018 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 04/27/2028 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
06/12/2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 019 |
06/10/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 018 |
06/10/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 017 |
06/10/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 016 |
06/10/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 015 |
06/01/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 014 |
05/31/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 013 |
05/31/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 012 |
12/04/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 011 |
12/04/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 010 |
12/04/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 009 |
11/28/2018 | DOCK | D | ASSIGNED TO EXAMINER | 008 |
11/20/2018 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 007 |
11/15/2018 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 006 |
09/18/2018 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 005 |
09/18/2018 | ALIE | A | ASSIGNED TO LIE | 004 |
09/09/2018 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 003 |
08/20/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
08/14/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Michael J. Leonard |
CORRESPONDENCE ADDRESS | MICHAEL J. LEONARD FOX ROTHSCHILD LLP 997 LENOX DRIVE, BLDG. 3 LAWRENCEVILLE, NJ 08648-2311 |
DOMESTIC REPRESENTATIVE | NONE |